genetics

  • Bio
    Early cancer detection startup GRAIL closes on $900 million in Series B funding

    Early cancer detection startup GRAIL closes on $900 million in Series B funding

    Life sciences startups need a whole lot more cash than most and that’s certainly true for GRAIL, a cancer detection startup trying to figure out a way to find the “emperor of all maladies” much earlier through blood testing technology. The startup, which spun out of genomics company Illumina announced it has closed a whopping $900 million in Series B funding this… Read More

  • Bio
    Illumina wants to sequence your whole genome for $100

    Illumina wants to sequence your whole genome for $100

    The first sequencing of the whole human genome in 2003 cost roughly $2.7 billion, but DNA sequencing giant Illumina has now unveiled a new machine that the company says is “expected one day” to order up your whole genome for less than $100. Illumina’s CEO Francis deSouza showed off the machine, called the NovaSeq, onstage at the JP Morgan Healthcare Conference in downtown… Read More

  • Bio
    Move over Cas9, CRISPR-Cas3 might hold the key to solving the antibiotics crisis

    Move over Cas9, CRISPR-Cas3 might hold the key to solving the antibiotics crisis

    Researchers at North Carolina-based Locus Biosciences think they have a potential cure for antibiotic resistance using CRISPR’s lesser-known Cas3 enzyme. Most of the interest in CRISPR technology centers around the enzyme Cas9, which acts as a type of genetic scissors, allowing scientists to snip out, edit and replace DNA at certain intervals along the genome. However, Cas3 goes beyond… Read More

  • Bio
    Chinese scientists CRISPR a human for the first time

    Chinese scientists CRISPR a human for the first time

    A group of Chinese scientists injected a human being with cells genetically edited using CRISPR-Cas9 technology. This is the first time CRISPR has been used on a fully formed adult human and it’s encouraged a biomedical battle between China and the United States. The scientists from China are hoping the genetically edited cells will help their patient fend off a virulent type of… Read More

  • Bio
    Oral arguments for who owns CRISPR-Cas9 start next month

    Oral arguments for who owns CRISPR-Cas9 start next month

    The date has been set for oral arguments to begin over who owns the patent rights to the gene-editing wonder CRISPR-Cas9. Berkeley’s Jennifer Doudna and her colleague from the Max Planck Institute Emmanuelle Charpentier head to court on December 6th to face off against MIT’s Feng Zhang and present their argument before three US Patent and Trademark Office judges on why… Read More

  • Bio
    Genetics startup Genos wants to pay you for your DNA data

    Genetics startup Genos wants to pay you for your DNA data

    The first whole human genome sequencing cost a whopping $2.7 billion. That didn’t bode well for making any breakthroughs on genetic disorders. Luckily, the cost has dropped dramatically since then, leading to a new breed of consumer genetics startups taking a deeper dive into all the double helix’s that make up you. Genos is one of those startups using a next-generation… Read More

  • Bio
    Gut health startup uBiome has raised $15.5 million and is launching a DNA test for your poop

    Gut health startup uBiome has raised $15.5 million and is launching a DNA test for your poop

    There are a lot of startups looking at your DNA these days but uBiome stands out as unique among them for testing the DNA of microorganisms found in your fecal matter. These bugs have a lot to do with your health and the startup is launching a clinical screening test called SmartGut to sequence the DNA of those microbes. uBiome tells TechCrunch it has also closed on $15.5 million in Series… Read More

  • 23andMe reportedly no longer working on next-gen sequencing

    23andMe reportedly no longer working on next-gen sequencing

    23andMe won’t continue with next-generation DNA sequencing and has reportedly laid off the lab working on the project. About half-a-dozen workers were laid off from the Salt Lake City, Utah-based lab, according to BuzzFeed, which first reported the news. By our own count based on LinkedIn, at least five members of the lab have been let go, including its chief medical officer, Dr. Read More

  • Bio
    23andMe’s Anne Wojcicki has a plan to include better genetic data from people of color

    23andMe’s Anne Wojcicki has a plan to include better genetic data from people of color

    One of the first consumer genetic testing companies, 23andMe says it aims to be at the forefront in gathering genetically diverse data throughout the world. The company just launched a standalone $99 ancestry service today as a way to offer those interested in their genetic lineage the ability to trace ancestors and relatives just by spitting into a tube. Ancestral DNA is something founder… Read More